Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous versus intramuscular methadone for pain relief in ICU patients
IRCT20160307026950N87Phase 3Recruiting
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Nov 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of methadone in pain (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Duration of sedation maintenance, Time to target sedation and 1 more. Started Nov 2026; status: recruiting.
02
Drugs
methadone
03
Conditions
pain
Beyond the preview
Go deeper on IRCT20160307026950N87.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N87.